iSpecimen Inc. Stock Issued During Period, Value, Restricted Stock Award, Gross
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- iSpecimen Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2026-03-31 was $875.00, a 94.06% decline year-over-year.
- iSpecimen Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2025-09-30 was $1.70K, a 96.20% decline year-over-year.
- iSpecimen Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2025-06-30 was $1.87K, a 95.83% decline year-over-year.
- iSpecimen Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2025-03-31 was $14.74K, a 69.32% decline year-over-year.
- iSpecimen Inc. stock issued during period, value, restricted stock award, gross for fiscal 2025 was $19.93K, a 86.52% decline from fiscal 2024.
- iSpecimen Inc. stock issued during period, value, restricted stock award, gross for fiscal 2024 was $147.83K, a 50.67% decline from fiscal 2023.
- iSpecimen Inc. stock issued during period, value, restricted stock award, gross for fiscal 2023 was $299.66K.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 3 month | Stock Issued During Period, Value, Restricted Stock Award, Gross 12 month |
|---|---|---|
| 2026-03-31 | $875.00 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $19.93K 10-K · filed 2026-04-01 | |
| 2025-09-30 | $1.70K 10-Q · filed 2025-11-17 | |
| 2025-06-30 | $1.87K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $14.74K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $147.83K 10-K · filed 2026-04-01 | |
| 2024-09-30 | $44.84K 10-Q · filed 2025-11-17 | |
| 2024-06-30 | $44.80K 10-Q · filed 2025-11-17 | |
| 2024-03-31 | $48.05K 10-Q · filed 2025-11-17 | |
| 2023-12-31 | $299.66K 10-K · filed 2025-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |